Business Context and Reporting Period
Accendra Health, Inc. filed this Form 8-K on June 23, 2026, to report the expiration and final settlement of exchange offers and consent solicitations for its outstanding senior notes. The company is incorporated in Virginia and trades on the New York Stock Exchange under the symbol ACH.
Key Financial Metrics and Debt Restructuring
The filing details a significant debt restructuring event rather than standard operating financial metrics. Key figures include:
- 2029 Notes Tendered: Approximately $478.3 million (99.9% of outstanding principal).
- 2030 Notes Tendered: Approximately $548.0 million (99.2% of outstanding principal).
- Remaining Existing Debt: $338,000 in 2029 Notes and $4.17 million in 2030 Notes.
- New Debt Issued (Exchange): $213.0 million in First Lien Notes and $698.1 million in Second Lien Notes.
- New Debt Issued (New Money): $326.25 million in First Lien Notes.
- Total New First Lien Notes: $539.25 million.
The filing text does not provide clear values for revenue, profit, cash flow, or operating margins.
Material Changes Versus Prior Period
The primary material change is the near-total replacement of the company's existing senior notes (4.500% due 2029 and 6.625% due 2030) with new First and Second Lien Notes. This transaction effectively retired approximately $1.026 billion of the previous debt structure, leaving only minimal amounts of the original notes outstanding.
Outlook, Risks, and Management Commentary
Management announced the successful completion of the exchange offers, with valid tenders accepted and cancelled on June 25, 2026. The new Second Lien Notes were issued pursuant to an indenture dated June 15, 2026, with Regions Bank serving as trustee and collateral agent. The filing does not contain specific forward-looking guidance, risk factors, or commentary on future operational performance beyond the completion of this capital structure transaction.
Investor Verification Checklist
- Verify the specific interest rates and maturity dates of the new First and Second Lien Notes issued in the exchange.
- Confirm the total aggregate principal amount of debt outstanding post-settlement ($539.25 million First Lien + $698.1 million Second Lien + residual Existing Notes).
- Review the terms of the Second Lien Indenture dated June 15, 2026, for covenants and collateral requirements.
- Assess the impact of the new debt structure on the company's liquidity and future interest expense obligations.